June 2018

Extend your professional repertoire with a published work based on a lecture or poster you have already created.

This letter from the Chairman and CEO of Oncology Nursing News gives an overview of the contents of the June 2018 print issue of the magazine.

The phase IIb UNITY-NHL clinical trial (NCT02793583) aims to determine whether the novel drug umbralisib (TGR-1202) could be used as monotherapy or in combination with other drugs to treat patients with relapsed/refractory non-Hodgkin lymphoma (NHL).

How does financial toxicity affect patients, and what can nurses do to help?

Selinexor (KPT-330), a promising drug that retards cell malignancy by blocking the transport of tumor-suppressor proteins out of the cell nucleus, is under investigation as combination therapy in heavily pretreated patients with relapsed/refractory multiple myeloma.

Government efforts to decrease unnecessary opioids use and reduce opioid diversion are creating a worrisome impact on cancer pain management.

Research has shown that pain and anxiety are related to port access, so a need exists to capture patients’ feelings and emotions related to living with a port, as well as effective nursing interventions aimed at addressing those patient experiences.

The rhythmic sounds and sensations of drumming can be healing for patients with breast cancer.

Sam didn’t understand the scope or severity of his illness until his nurse navigator intervened.

A foundational volume in oncology nursing gets an upgrade.

One small group of oncology nurses in a large hospital system developed an innovative nursing position to satisfy both patients and providers.

A thousand oncology nurses celebrate CURE® Extraordinary Healer® Award recipients at annual ceremony.

Christine Stone, MSN, RN, OCN, winner of the 2018 CURE Extraordinary Healer in Oncology Nursing award, sees her work as her calling.